> top > docs > PubMed:17623722 > annotations

PubMed:17623722 JSONTXT

Annnotations TAB JSON ListView MergeView

Glycan-Motif

Id Subject Object Predicate Lexical cue
T1 51-59 https://glytoucan.org/Structures/Glycans/G00021MO denotes heparins
T2 51-59 https://glytoucan.org/Structures/Glycans/G54161DR denotes heparins
T3 1035-1042 https://glytoucan.org/Structures/Glycans/G00021MO denotes heparin
T4 1035-1042 https://glytoucan.org/Structures/Glycans/G54161DR denotes heparin

GlyCosmos6-Glycan-Motif-Image

Id Subject Object Predicate Lexical cue image
T1 51-59 Glycan_Motif denotes heparins https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO
T3 1035-1042 Glycan_Motif denotes heparin https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-91 Sentence denotes Towards GAG glycomics: analysis of highly sulfated heparins by MALDI-TOF mass spectrometry.
TextSentencer_T2 92-235 Sentence denotes Glycomics is a developing field that provides structural information on complex populations of glycans isolated from tissues, cells and organs.
TextSentencer_T3 236-382 Sentence denotes Strategies employing matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) are central to glycomic analysis.
TextSentencer_T4 383-743 Sentence denotes Current MALDI-based glycomic strategies are capable of efficiently analyzing glycoprotein and glycosphingolipid glycomes but little attention has been paid to devising glycomic methodologies suited to the analysis of glycosaminoglycan (GAG) polysaccharides which pose special problems for MALDI analysis because of their high level of sulfation and large size.
TextSentencer_T5 744-878 Sentence denotes In this paper, we describe MALDI strategies that have been optimized for the analysis of highly sulfated GAG-derived oligosaccharides.
TextSentencer_T6 879-1119 Sentence denotes A crystalline matrix norharmane, as well as an ionic liquid 1-methylimidazolium alpha-cyano-4-hydroxycinnamate (ImCHCA), have been used for the analysis of heparin di-, tetra-, hexa- and decasaccharides carrying from 2 to 13 sulfate groups.
TextSentencer_T7 1120-1441 Sentence denotes Information about the maximum number of sulfate groups is obtained using the ionic liquid whereas MALDI-TOF/TOF MS/MS experiments using norharmane allowed the determination of the nature of the glycosidic backbone, and more precise information about the presence and the position in the sequence of N-acetylated residues.
T1 0-91 Sentence denotes Towards GAG glycomics: analysis of highly sulfated heparins by MALDI-TOF mass spectrometry.
T2 92-235 Sentence denotes Glycomics is a developing field that provides structural information on complex populations of glycans isolated from tissues, cells and organs.
T3 236-382 Sentence denotes Strategies employing matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) are central to glycomic analysis.
T4 383-743 Sentence denotes Current MALDI-based glycomic strategies are capable of efficiently analyzing glycoprotein and glycosphingolipid glycomes but little attention has been paid to devising glycomic methodologies suited to the analysis of glycosaminoglycan (GAG) polysaccharides which pose special problems for MALDI analysis because of their high level of sulfation and large size.
T5 744-878 Sentence denotes In this paper, we describe MALDI strategies that have been optimized for the analysis of highly sulfated GAG-derived oligosaccharides.
T6 879-1119 Sentence denotes A crystalline matrix norharmane, as well as an ionic liquid 1-methylimidazolium alpha-cyano-4-hydroxycinnamate (ImCHCA), have been used for the analysis of heparin di-, tetra-, hexa- and decasaccharides carrying from 2 to 13 sulfate groups.
T7 1120-1441 Sentence denotes Information about the maximum number of sulfate groups is obtained using the ionic liquid whereas MALDI-TOF/TOF MS/MS experiments using norharmane allowed the determination of the nature of the glycosidic backbone, and more precise information about the presence and the position in the sequence of N-acetylated residues.
T1 0-91 Sentence denotes Towards GAG glycomics: analysis of highly sulfated heparins by MALDI-TOF mass spectrometry.
T2 92-235 Sentence denotes Glycomics is a developing field that provides structural information on complex populations of glycans isolated from tissues, cells and organs.
T3 236-382 Sentence denotes Strategies employing matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) are central to glycomic analysis.
T4 383-743 Sentence denotes Current MALDI-based glycomic strategies are capable of efficiently analyzing glycoprotein and glycosphingolipid glycomes but little attention has been paid to devising glycomic methodologies suited to the analysis of glycosaminoglycan (GAG) polysaccharides which pose special problems for MALDI analysis because of their high level of sulfation and large size.
T5 744-878 Sentence denotes In this paper, we describe MALDI strategies that have been optimized for the analysis of highly sulfated GAG-derived oligosaccharides.
T6 879-1119 Sentence denotes A crystalline matrix norharmane, as well as an ionic liquid 1-methylimidazolium alpha-cyano-4-hydroxycinnamate (ImCHCA), have been used for the analysis of heparin di-, tetra-, hexa- and decasaccharides carrying from 2 to 13 sulfate groups.
T7 1120-1441 Sentence denotes Information about the maximum number of sulfate groups is obtained using the ionic liquid whereas MALDI-TOF/TOF MS/MS experiments using norharmane allowed the determination of the nature of the glycosidic backbone, and more precise information about the presence and the position in the sequence of N-acetylated residues.

GlyCosmos6-Glycan-Motif-Structure

Id Subject Object Predicate Lexical cue
T1 51-59 https://glytoucan.org/Structures/Glycans/G00021MO denotes heparins
T2 51-59 https://glytoucan.org/Structures/Glycans/G54161DR denotes heparins
T3 1035-1042 https://glytoucan.org/Structures/Glycans/G00021MO denotes heparin
T4 1035-1042 https://glytoucan.org/Structures/Glycans/G54161DR denotes heparin

GlycoBiology-GDGDB

Id Subject Object Predicate Lexical cue
_T1 1056-1060 http://acgg.asia/db/diseases/gdgdb?con_ui=CON00055 denotes hexa
_T2 1056-1060 http://acgg.asia/db/diseases/gdgdb?con_ui=CON00056 denotes hexa
_T3 1056-1060 http://acgg.asia/db/diseases/gdgdb?con_ui=CON00057 denotes hexa

uniprot-human

Id Subject Object Predicate Lexical cue
T1 345-347 http://www.uniprot.org/uniprot/Q99707 denotes MS
T2 1232-1234 http://www.uniprot.org/uniprot/Q99707 denotes MS
T3 1235-1237 http://www.uniprot.org/uniprot/Q99707 denotes MS

uniprot-mouse

Id Subject Object Predicate Lexical cue
T1 345-347 http://www.uniprot.org/uniprot/A6H5Y3 denotes MS
T2 1232-1234 http://www.uniprot.org/uniprot/A6H5Y3 denotes MS
T3 1235-1237 http://www.uniprot.org/uniprot/A6H5Y3 denotes MS
T4 1056-1060 http://www.uniprot.org/uniprot/P29416 denotes hexa

GlycoBiology-NCBITAXON

Id Subject Object Predicate Lexical cue
T1 209-216 http://purl.bioontology.org/ontology/STY/T024 denotes tissues
T2 218-223 http://purl.bioontology.org/ontology/STY/T025 denotes cells
T3 273-278 http://purl.bioontology.org/ontology/NCBITAXON/62990 denotes laser
T4 1048-1053 http://purl.bioontology.org/ontology/NCBITAXON/85284 denotes tetra
T5 1048-1053 http://purl.bioontology.org/ontology/NCBITAXON/1310384 denotes tetra
T6 1112-1118 http://purl.bioontology.org/ontology/STY/T096 denotes groups
T7 1168-1174 http://purl.bioontology.org/ontology/STY/T096 denotes groups

GO-BP

Id Subject Object Predicate Lexical cue
T1 42-50 http://purl.obolibrary.org/obo/GO_0051923 denotes sulfated
T2 718-727 http://purl.obolibrary.org/obo/GO_0051923 denotes sulfation
T3 1104-1111 http://purl.obolibrary.org/obo/GO_0051923 denotes sulfate
T4 1160-1167 http://purl.obolibrary.org/obo/GO_0051923 denotes sulfate
T5 107-117 http://purl.obolibrary.org/obo/GO_0032502 denotes developing
T6 309-315 http://purl.obolibrary.org/obo/GO_0060361 denotes flight

GO-CC

Id Subject Object Predicate Lexical cue
T1 218-223 http://purl.obolibrary.org/obo/GO_0005623 denotes cells

UBERON-AE

Id Subject Object Predicate Lexical cue
T1 209-216 http://purl.obolibrary.org/obo/UBERON_0000479 denotes tissues
T2 228-234 http://purl.obolibrary.org/obo/UBERON_0000062 denotes organs
T3 353-360 http://purl.obolibrary.org/obo/UBERON_0012131 denotes central

GlyTouCan-IUPAC

Id Subject Object Predicate Lexical cue
GlycanIUPAC_T1 1056-1060 "http://rdf.glycoinfo.org/glycan/G81168AE" denotes hexa
GlycanIUPAC_T2 1056-1060 "http://rdf.glycoinfo.org/glycan/G90684IR" denotes hexa
GlycanIUPAC_T3 1056-1060 "http://rdf.glycoinfo.org/glycan/G32900AW" denotes hexa
GlycanIUPAC_T4 1056-1060 "http://rdf.glycoinfo.org/glycan/G72029GV" denotes hexa
GlycanIUPAC_T5 1056-1060 "http://rdf.glycoinfo.org/glycan/G69792ST" denotes hexa
GlycanIUPAC_T6 1056-1060 "http://rdf.glycoinfo.org/glycan/G18081CC" denotes hexa
GlycanIUPAC_T7 1056-1060 "http://rdf.glycoinfo.org/glycan/G39201OW" denotes hexa

GlycoBiology-Motifs

Id Subject Object Predicate Lexical cue
T1 51-59 http://rdf.glycoinfo.org/glycan/G54161DR denotes heparins
T2 1035-1042 http://rdf.glycoinfo.org/glycan/G54161DR denotes heparin

performance-test

Id Subject Object Predicate Lexical cue
PD-UBERON-AE-B_T1 209-216 http://purl.obolibrary.org/obo/UBERON_0000479 denotes tissues
PD-UBERON-AE-B_T2 228-234 http://purl.obolibrary.org/obo/UBERON_0000062 denotes organs
PD-UBERON-AE-B_T3 353-360 http://purl.obolibrary.org/obo/UBERON_0012131 denotes central

Anatomy-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 1325-1333 Body_part denotes backbone http://purl.obolibrary.org/obo/UBERON_0001130